2m 2m 2m 2m 2m 2m 2m
NANO-X IMG (NNOX)
NASDAQ
$1.81-$0.11 (-5.99%)
Price as of Jun 03, 2026 7:54 PM EDT- $99.4MMarket Cap
- -63.84%1-Year Change
- Medical DevicesIndustry
NANO-X IMG (NNOX)
$1.81-$0.11 (-5.99%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.0M +15.40% | 11.3M +13.91% | 9.9M +15.47% | 8.6M +557.82% | |
Cost of Revenue | 25.8M +17.89% | 21.9M +32.70% | 16.5M +6.72% | 15.5M +448.93% | |
Gross Profit | -12.8M +20.54% | -10.6M +60.94% | -6.6M -4.19% | -6.9M +355.03% | |
Sales and Marketing Expense | 5.7M +66.13% | 3.4M -18.19% | 4.2M -4.75% | 4.4M -37.78% | |
Research and Development Expense | -19.2M -4.69% | -20.2M -22.52% | -26.0M -1.73% | -26.5M +54.81% | |
Depreciation and Amortization Expense | 10.5M -0.98% | 10.6M 0.00% | 10.6M +0.05% | 10.6M +499.94% | |
Total Operating Expenses | 65.4M +41.85% | 46.1M -17.61% | 56.0M -49.47% | 110.8M +84.58% | |
Operating Profit | -78.2M +37.87% | -56.7M -9.34% | -62.6M -46.83% | -117.7M +91.22% | |
Interest Income | N/A N/A | 2,000 +101.12% | -178,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 -100.00% | 2,000 +101.12% | -178,000 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 1.4M -50.38% | 2.9M +73.73% | 1.7M +109.38% | 789,000 +373.96% | |
Income before Taxes | -76.8M +42.57% | -53.9M -11.85% | -61.1M -47.73% | -116.9M +89.05% | |
Income Taxes | -1.8M +400.56% | -358,000 +5.60% | -339,000 -90.78% | -3.7M +7,562.50% | |
Extraordinary Items | 17.5M +8,577.23% | 202,000 -84.43% | 1.3M N/A | N/A N/A | |
Net Income | -75.0M +40.18% | -53.5M -11.95% | -60.8M -46.33% | -113.2M +83.25% | |
Net Income from Continuing Operations Applicable to Common | -76.8M +42.57% | -53.9M -11.85% | -61.1M -47.73% | -116.9M +89.05% | |
Basic EPS and Net Income | -1.16 +27.47% | -0.91 -15.74% | -1.08 -50.23% | -2.17 +69.53% | |
Diluted EPS and Net Income | -1.16 +27.47% | -0.91 -15.74% | -1.08 -50.23% | -2.17 +69.53% | |
Basic Weighted Average Shares | 64,790 -99.89% | 58.7M +103,989.20% | 56,368 +7.91% | 52,235 +8.34% | |
Diluted Weighted Average Shares | 64,790 -99.89% | 58.7M +103,989.20% | 56,368 +7.91% | 52,235 +8.34% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 49.2M +25.05% | 39.3M -30.28% | 56.4M +46.57% | 38.5M -42.29% | |
Short-Term Investments | N/A N/A | 18.4M -29.24% | 26.0M -33.59% | 39.2M +77.47% | |
Cash and Cash Equivalents and Short-Term Investments | 49.2M -14.83% | 57.7M -29.95% | 82.4M +6.13% | 77.6M -12.50% | |
Total Current Assets | 66.8M -15.11% | 78.7M -11.23% | 88.6M +7.49% | 82.5M -13.07% | |
Accumulated Depreciation | 5.6M -1.00% | 5.7M +111.04% | 2.7M +61.82% | 1.7M +91.59% | |
Property and Plant and Equipment and Net | 29.7M -34.57% | 45.4M +7.11% | 42.3M -2.76% | 43.5M +16.32% | |
Total Long-Term Assets | 95.4M -27.38% | 131.3M +1.01% | 130.0M -24.18% | 171.5M -36.09% | |
Total Assets | 162.2M -22.78% | 210.0M -3.95% | 218.6M -13.90% | 253.9M -30.08% | |
Income Taxes Payable | 600,000 -76.71% | 2.6M -12.77% | 3.0M -11.32% | 3.3M -52.85% | |
Total Short-Term Debt | 3.1M +2.45% | 3.1M -74.47% | 12.0M +8,226.39% | 144,000 -0.69% | |
Total Current Liabilities | 16.9M +20.87% | 14.0M -10.00% | 15.5M -38.09% | 25.1M -52.47% | |
Total Long-Term Debt | 173,000 -97.45% | 6.8M +0.24% | 6.8M +94.08% | 3.5M -8.30% | |
Total Long-Term Liabilities | 5.5M -19.77% | 6.9M -9.19% | 7.6M -37.52% | 12.2M -33.34% | |
Total Liabilities | 22.4M +7.42% | 20.9M -9.73% | 23.1M -37.90% | 37.3M -47.55% | |
Retained Earnings | -448.8M +20.07% | -373.7M +16.71% | -320.2M +23.42% | -259.5M +77.45% | |
Total Stockholders Equity | 139.7M -26.11% | 189.1M -3.27% | 195.5M -9.77% | 216.7M -25.83% | |
Total Shares Outstanding | 69.6M +9.14% | 63.8M +10.36% | 57.8M +4.87% | 55.1M +6.38% | |
Cash Flow | |||||
Cash from Operating Activities | -40.8M +11.46% | -36.6M -18.27% | -44.8M +3.21% | -43.4M +13.96% | |
Capital Expenditures | 4.2M +52.04% | 2.8M -16.23% | 3.3M -53.94% | 7.2M -69.03% | |
Cash from Investing Activities | 29.4M +246.49% | -20.1M -156.59% | 35.4M +142.59% | 14.6M +112.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 21.4M -45.91% | 39.5M +44.96% | 27.3M +3,289.55% | 804,000 -89.10% | |
Financials Ratio | |||||
Gross Margin | -98.21% +4.45% | -94.03% +41.28% | -66.55% -17.02% | -80.21% -30.83% | |
Operating Margin | -600.83% +19.46% | -502.93% -20.41% | -631.89% -53.95% | -1,372.23% -70.93% | |
Return on Assets | -40.31% +61.45% | -24.97% -2.92% | -25.72% -29.92% | -36.70% +77.97% | |
Return on Equity | -45.62% +63.96% | -27.83% -5.64% | -29.49% -33.75% | -44.51% +88.31% | |
Revenue Growth | 15.40% +10.72% | 13.91% -10.07% | 15.47% -97.23% | 557.82% N/A | |
Current Ratio | 3.96 -29.77% | 5.63 -1.37% | 5.71 +73.61% | 3.29 +82.89% | |
Cash Ratio | 2.91 +3.46% | 2.81 -22.54% | 3.63 +136.74% | 1.53 +21.42% | |
Debt-to-Equity Ratio | 0.02 -54.42% | 0.05 -45.78% | 0.10 +474.25% | 0.02 +23.70% | |
Debt-to-Assets Ratio | 0.02 -56.41% | 0.05 -45.39% | 0.09 +499.30% | 0.01 +31.19% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow